🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will address the question of whether targeting CMV antigens with...
Status
Recruiting
Location
Children's Hospital Colorado
Start Date
2024-07-18
Trial ID
NCT05096481
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of the combi...
Status
Completed
Location
University of South Alabama, Mitchell Cancer Institute ( Site 0065)
Start Date
2019-05-02
Trial ID
NCT03834506
Treatments Being Tested
The objective of this study is to evaluate tolerability, safety and efficac...
Status
Completed
Location
Dipartimento "Organi di Senso" Università La Sapienza- Policlinico Umberto I
Start Date
2015-06-26
Trial ID
NCT02507934
Treatments Being Tested
This is a Phase 3, double-blind, randomized, placebo-controlled, multicente...
Status
Completed
Location
Children's Hospital of Los Angeles
Start Date
2016-05-02
Trial ID
NCT02604433
Treatments Being Tested
Although there have been remarkable advances in the treatment of metastatic...
Status
Completed
Location
Seoul National University Bundang Hospital
Start Date
2011-06
Trial ID
NCT01409005
Treatments Being Tested
The purpose of this study is to see if two new malaria vaccines called FMP1...
Status
Completed
Location
WRAIR Clinical Trials Center
Start Date
2001-04
Trial ID
NCT01556945
Treatments Being Tested
The primary scientific question of interest of this study is whether the co...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-09-15
Trial ID
NCT05809895
Treatments Being Tested
A Phase I dose-finding stage for the LB-100 plus doxorubicin combination is...
Status
Active Not Recruiting
Location
Hospital de la Santa Creu i Sant Pau
Start Date
2023-05-29
Trial ID
NCT05809830
Treatments Being Tested
The purpose of this study was to determine the safety of AZX100 Drug Produc...
Status
Completed
Location
Lotus Clinical Research, Inc.
Start Date
2009-01
Trial ID
NCT00811577
The safety and efficacy of pembrolizumab plus the investigator's choice of ...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham-Medicine ( Site 0065)
Start Date
2021-06-18
Trial ID
NCT04895358
Treatments Being Tested